Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Clover HealthCLOV |
-$344M |
 |
AflacAFL |
-$684B |
 |
ProgressivePGR |
-$1.81B |
 |
CenteneCNC |
$61M |
 |
Root InsuranceROOT |
-$733M |
Are MetLife Insiders Buying or Selling?
MetLife (MET) has had 1 insider transaction in the past 90 days, all sells. The most recent was MARLENE DEBEL, who sold 21,312 shares at $81.59 on June 1, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the MET AI Score. For government officials trading this stock, see MET congressional trading.
Who’s Trading MetLife Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| MARLENE DEBEL | Sold $3.6M | 2 | Jun 1, 2026 |
| BILL PAPPAS | Sold $2.1M | 1 | May 12, 2025 |
| Michel Khalaf | Sold $1.7M | 1 | Dec 13, 2024 |
Recent MetLife Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| MARLENE DEBEL | Jun 1, 2026 | Sell | 21,312 | $81.59 | $1.7M |
| BILL PAPPAS | May 12, 2025 | Sell | 26,000 | $80.49 | $2.1M |
| MARLENE DEBEL | Dec 13, 2024 | Sell | 22,810 | $82.88 | $1.9M |
| Michel Khalaf | Dec 13, 2024 | Sell | 20,926 | $82.84 | $1.7M |
Frequently Asked Questions: MetLife Insider Trading
In the past 90 days, MetLife insiders have made 0 buys and 1 sell. The net selling may indicate insiders are taking profits or reducing exposure.
The most recent sale was by MARLENE DEBEL who sold 21,312 shares on June 1, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
DEBEL MARLENE has sold the most MET stock in the last 2 years, with a total value of $3.6M.
The total value of insider transactions for MetLife in the last 2 years is negative, amounting to -$7.5M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
